Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US......
The US Food and Drug Administration has issued a warning letter to Ranbaxy Laboratories' American subsidiary Ohm Laboratories for violating current good manufacturing practice norms. "Ohm......
Ranbaxy Laboratories is recalling 29,790 blister packs of anti-allergy drug in the US, manufactured by its arm Ohms Laboratories, due to defective packaging. According to the US health......
Drug major Ranbaxy Laboratories has launched its generic version of blockbuster cholesterol-lowering drug Lipitor in the US market.The launch came after final approval from the US health regulator......
Ranbaxy Laboratories on Thursday said it had received Abbreviated New Drug Application approval from the US Food and Drug Administration to manufacture and market Loratidine, a generic version of......